ARS Pharmaceuticals, Inc.

Our corporate headquarters are located in San Diego, California, where we lease approximately 4,047 square feet of office space. On January 24, 2025, we entered into a lease amendment (“Headquarters Amendment”) for our corporate headquarters, pursuant to which we will relocate to a new premises located in the same building which consists of 9,254 rentable square feet of office space. We will take possession of the new office space when the landlord’s work is substantially complete, which is estimated to be July 1, 2025. We must vacate our current corporate headquarters within 15 days of taking possession of the new premises. Under the Headquarters Amendment, the term of the lease will be extended to 36 full calendar months following the date we take possession of the new office space. We believe that our existing facilities and those to be leased under the Headquarters Amendment are adequate for our current needs.